Medical Condition News

RSS

Less invasive procedure for heart disease

Doctors at Regions Hospital have begun performing a less invasive procedure for heart disease. Transcatheter aortic valve replacement (TAVR) was approved last November by the U.S. Food and Drug Administration for elderly patients who are too frail or too old for open heart surgery. The device is not approved for patients who are eligible for open heart surgery.

11 May 2012

Mylan introduces Atorvastatin Calcium in France, Belgium, UK, Ireland and the Netherlands

Mylan Inc. today announced that it has launched Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg in France, Belgium, the UK, the Netherlands and Ireland.

11 May 2012

Positive results from Cytochroma CTAP101 Phase 2b clinical trial for CKD

Cytochroma today announced positive clinical trial results for its lead product, CTAP101 Capsules. In a recently completed Phase 2b trial, CTAP101 Capsules effectively and safely lowered elevated plasma intact parathyroid hormone (iPTH) in patients with Stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.

11 May 2012

Study supports catheter ablation as first-line treatment for paroxysmal atrial fibrillation

Patients with the heart rhythm disorder atrial fibrillation (AFib) who received first-line catheter ablation treatment had a longer arrhythmia-free interval than patients receiving antiarrhythmic drugs, the standard first-line treatment.

11 May 2012

CTI receives EU conditional marketing authorization for Pixuvri to treat non-Hodgkin B-cell lymphomas

CellTherapeutics today announced that it has received conditional marketing authorization from the European Commission for Pixuvri (pixantrone) as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas. Pixuvri is the first approved treatment in the European Union in this patient setting.

11 May 2012

New discovery platform for antigen-specific monoclonal antibodies

Cell Signaling Technology, Inc. of Danvers, MA is pleased to announce the development of a new discovery platform for antigen-specific monoclonal antibodies.

From Cell Signaling Technology 11 May 2012

BIOTRONIK launches new Reocor external pacemaker

BIOTRONIK, Inc., announced today the U.S. launch of its new Reocor external pacemaker. The device is available in two models, for dual- and single-chamber pacing therapy, and offers individualized patient therapy, easy handling and flexibility in every detail. Reocor enriches BIOTRONIK's portfolio of high quality cardiovascular devices and sets a new standard of quality for external pacing therapy.

11 May 2012

Dyax introduces free Attack Tracker smartphone application for hereditary angioedema patients

Dyax Corp. today announced the launch of a free smartphone application for the iPhone - HAE Attack Tracker. This application allows HAE patients to keep detailed records of their disease related information, including emergency and physician contacts as well as individual attack data.

11 May 2012

Arno AR-42 for neurofibromatosis type 2 receives EMA orphan-drug designation

Arno Therapeutics, Inc. announced today that its investigational compound known as AR-42 has been granted orphan-drug designation by the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products for the treatment of neurofibromatosis type 2 (NF2).

11 May 2012

Rule change has consequences for dialysis patients

A shift last year by the federal government in how it pays for drugs to treat dialysis patients may have had an unintended and potentially dire consequence, according to new research: a significant jump in blood transfusions for patients who now may not be getting enough of the medications.

11 May 2012

Lot of fat and few carbohydrates could have better effect on blood sugar levels, lipids in diabetics

People with Type 2 diabetes are usually advised to keep a low-fat diet. Now, a study at Linköping University shows that food with a lot of fat and few carbohydrates could have a better effect on blood sugar levels and blood lipids.

11 May 2012

Discrepancies between recommendations and implementation for management of cardiovascular risk factors

There are discrepancies between the recommendations for the management of cardiovascular risk factors and their implementation in clinical practice. In the latest issue of Deutsches Ärzteblatt International, Christof Prugger and his fellow authors present the results of the EUROASPIRE I, II and III surveys in the Münster region of Germany.

11 May 2012

Two types of stent systems are both effective in treating iliac artery disease

Two types of stent systems are both effective in treating patients who have severe forms of peripheral artery disease (PAD), according to results of the MOBILITY trial presented today as a late-breaking clinical trial at the SCAI 2012 Scientific Sessions.

11 May 2012

Physically active video games can complement traditional exercise

The majority of consumers believe video games should encourage physical activity and that "physically active" video games can complement traditional exercise, according to a new survey released today by UnitedHealth Group.

11 May 2012

New combination therapy offers potential lifetime cure for advanced type 1 diabetes

City of Hope researchers developed a combination therapy to treat late-stage type 1 diabetes that appears to offer a potential lifetime cure for the disease without toxic side effects. The laboratory study is published in the May 9 edition of Science Translational Medicine.

11 May 2012

Cedars-Sinai’s first patient implanted with SynCardia temporary Total Artificial Heart

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, said today that Cedars-Sinai Medical Center in Los Angeles has discharged its first patient to be implanted with the SynCardia temporary Total Artificial Heart.

11 May 2012

PET imaging for sudden cardiac arrest can identify candidates for ICDs

New research from the University at Buffalo suggests that cardiologists may have a new way to identify patients who are at the highest risk of sudden cardiac arrest, and the most likely to benefit from receiving an implantable cardiac defibrillator (ICD).

11 May 2012

Top-line results from Takeda vedolizumab phase 3 trial on Crohn's disease

Takeda Pharmaceutical Company Limited today announced top-line results from the international, randomized, placebo-controlled, double-blind GEMINI II pivotal phase 3 trial. The trial evaluated vedolizumab in 1,115 patients with moderately to severely active Crohn's disease who have failed at least one conventional therapy, including TNFα antagonists.

11 May 2012

African-Americans with scleroderma have more antibodies linked to severe complications

A new analysis finds that compared to Caucasians, African-Americans with systemic scleroderma have more antibodies in the blood that are linked to severe complications and an increased likelihood of death. They say this finding, published today in Arthritis & Rheumatism, suggests physicians can use these disease markers to screen and treat scleroderma patients proactively.

11 May 2012

Excess brain activity contributes to amnestic mild cognitive impairment

A study led by a Johns Hopkins neuroscientist and published in the May 10 issue of the journal Neuron suggests a potential new therapeutic approach for improving memory and interrupting disease progression in patients with a form of cognitive impairment that often leads to full-blown Alzheimer's disease.

11 May 2012

Medical Condition News

Less invasive procedure for heart disease

Mylan introduces Atorvastatin Calcium in France, Belgium, UK, Ireland and the Netherlands

Positive results from Cytochroma CTAP101 Phase 2b clinical trial for CKD

Study supports catheter ablation as first-line treatment for paroxysmal atrial fibrillation

CTI receives EU conditional marketing authorization for Pixuvri to treat non-Hodgkin B-cell lymphomas

New discovery platform for antigen-specific monoclonal antibodies

BIOTRONIK launches new Reocor external pacemaker

Dyax introduces free Attack Tracker smartphone application for hereditary angioedema patients

Arno AR-42 for neurofibromatosis type 2 receives EMA orphan-drug designation

Rule change has consequences for dialysis patients

Lot of fat and few carbohydrates could have better effect on blood sugar levels, lipids in diabetics

Discrepancies between recommendations and implementation for management of cardiovascular risk factors

Two types of stent systems are both effective in treating iliac artery disease

Physically active video games can complement traditional exercise

New combination therapy offers potential lifetime cure for advanced type 1 diabetes

Cedars-Sinai’s first patient implanted with SynCardia temporary Total Artificial Heart

PET imaging for sudden cardiac arrest can identify candidates for ICDs

Top-line results from Takeda vedolizumab phase 3 trial on Crohn's disease

African-Americans with scleroderma have more antibodies linked to severe complications

Excess brain activity contributes to amnestic mild cognitive impairment

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News